A detailed history of Raymond James & Associates transactions in Agilent Technologies, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 100,398 shares of A stock, worth $13.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
100,398
Previous 118,388 15.2%
Holding current value
$13.8 Million
Previous $15.3 Million 2.86%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$125.42 - $148.48 $2.26 Million - $2.67 Million
-17,990 Reduced 15.2%
100,398 $14.9 Million
Q2 2024

Jul 19, 2024

SELL
$129.63 - $154.64 $1.3 Million - $1.56 Million
-10,059 Reduced 7.83%
118,388 $15.3 Million
Q1 2024

Apr 22, 2024

BUY
$128.12 - $149.31 $3.01 Million - $3.5 Million
23,473 Added 22.36%
128,447 $18.7 Million
Q4 2023

Jan 16, 2024

BUY
$101.17 - $139.82 $2.93 Million - $4.05 Million
28,965 Added 38.11%
104,974 $14.6 Million
Q3 2023

Oct 24, 2023

SELL
$109.73 - $128.47 $1.77 Million - $2.08 Million
-16,164 Reduced 17.54%
76,009 $8.5 Million
Q2 2023

Jul 25, 2023

SELL
$114.69 - $141.28 $2.18 Million - $2.69 Million
-19,033 Reduced 17.12%
92,173 $11.1 Million
Q1 2023

Apr 14, 2023

BUY
$131.13 - $159.06 $643,586 - $780,666
4,908 Added 4.62%
111,206 $15.4 Million
Q4 2022

Feb 08, 2023

BUY
$125.64 - $157.68 $46,738 - $58,656
372 Added 0.35%
106,298 $15.9 Million
Q3 2022

Oct 25, 2022

BUY
$115.11 - $142.29 $329,444 - $407,233
2,862 Added 2.78%
105,926 $12.9 Million
Q2 2022

Aug 12, 2022

SELL
$112.71 - $135.93 $1.99 Million - $2.4 Million
-17,673 Reduced 14.64%
103,064 $12.2 Million
Q1 2022

May 11, 2022

SELL
$126.0 - $156.48 $513,702 - $637,968
-4,077 Reduced 3.27%
120,737 $16 Million
Q4 2021

Feb 08, 2022

BUY
$147.95 - $164.3 $4.86 Million - $5.4 Million
32,857 Added 35.73%
124,814 $19.9 Million
Q3 2021

Nov 02, 2021

SELL
$147.58 - $179.28 $2.55 Million - $3.09 Million
-17,245 Reduced 15.79%
91,957 $14.5 Million
Q2 2021

Aug 11, 2021

BUY
$127.69 - $148.81 $5.36 Million - $6.25 Million
41,996 Added 62.49%
109,202 $16.1 Million
Q1 2021

May 14, 2021

SELL
$114.99 - $130.12 $179,269 - $202,857
-1,559 Reduced 2.27%
67,206 $8.55 Million
Q4 2020

Feb 12, 2021

BUY
$100.01 - $119.3 $1.61 Million - $1.92 Million
16,127 Added 30.64%
68,765 $8.15 Million
Q3 2020

Nov 04, 2020

BUY
$88.11 - $103.42 $462,225 - $542,541
5,246 Added 11.07%
52,638 $5.31 Million
Q2 2020

Jul 28, 2020

BUY
$68.92 - $91.14 $399,046 - $527,700
5,790 Added 13.92%
47,392 $4.19 Million
Q1 2020

Apr 21, 2020

SELL
$63.37 - $90.13 $59,441 - $84,541
-938 Reduced 2.2%
41,602 $2.98 Million
Q4 2019

Feb 12, 2020

BUY
$72.49 - $85.45 $28,633 - $33,752
395 Added 0.94%
42,540 $3.63 Million
Q3 2019

Nov 07, 2019

SELL
$65.59 - $78.07 $1.59 Million - $1.9 Million
-24,301 Reduced 36.57%
42,145 $3.23 Million
Q2 2019

Aug 06, 2019

SELL
$66.89 - $81.94 $3.18 Million - $3.89 Million
-47,471 Reduced 41.67%
66,446 $4.96 Million
Q1 2019

May 06, 2019

BUY
$63.27 - $82.0 $2 Million - $2.59 Million
31,559 Added 38.32%
113,917 $9.16 Million
Q4 2018

Feb 11, 2019

BUY
$61.13 - $74.67 $86,865 - $106,106
1,421 Added 1.76%
82,358 $5.56 Million
Q3 2018

Nov 14, 2018

BUY
$61.25 - $71.13 $382,751 - $444,491
6,249 Added 8.37%
80,937 $5.71 Million
Q2 2018

Aug 14, 2018

BUY
$61.14 - $69.55 $964,666 - $1.1 Million
15,778 Added 26.78%
74,688 $4.62 Million
Q1 2018

May 14, 2018

BUY
$65.05 - $74.82 $31,028 - $35,689
477 Added 0.82%
58,910 $3.94 Million
Q4 2017

Feb 14, 2018

BUY
$64.87 - $70.59 $73,497 - $79,978
1,133 Added 1.98%
58,433 $3.91 Million
Q3 2017

Nov 13, 2017

BUY
$58.57 - $66.17 $1.72 Million - $1.94 Million
29,296 Added 104.61%
57,300 $3.68 Million
Q2 2017

Aug 14, 2017

BUY
N/A
28,004
28,004 $1.66 Million

Others Institutions Holding A

About AGILENT TECHNOLOGIES, INC.


  • Ticker A
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 296,040,992
  • Market Cap $40.7B
  • Description
  • Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatogra...
More about A
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.